1. Home
  2. III vs MIST Comparison

III vs MIST Comparison

Compare III & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.14

Market Cap

193.7M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.25

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
III
MIST
Founded
2006
2003
Country
United States
Canada
Employees
1500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.7M
176.3M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
III
MIST
Price
$4.14
$1.25
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.50
$8.00
AVG Volume (30 Days)
199.4K
1.3M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
4.46%
N/A
EPS Growth
216.67
N/A
EPS
0.05
N/A
Revenue
$192,745,000.00
N/A
Revenue This Year
$3.85
$2,915.14
Revenue Next Year
$4.34
N/A
P/E Ratio
$81.20
N/A
Revenue Growth
4.51
N/A
52 Week Low
$3.74
$1.00
52 Week High
$6.45
$3.06

Technical Indicators

Market Signals
Indicator
III
MIST
Relative Strength Index (RSI) 50.82 34.18
Support Level $3.95 $1.20
Resistance Level $4.37 $1.42
Average True Range (ATR) 0.14 0.07
MACD -0.01 0.01
Stochastic Oscillator 75.56 20.45

Price Performance

Historical Comparison
III
MIST

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: